Chargement en cours...
Novel Biomarkers for Personalized Cancer Immunotherapy
Cancer immunotherapy has emerged as a novel and effective treatment strategy for several types of cancer. Immune checkpoint inhibitors (ICIs) have recently demonstrated impressive clinical benefit in some advanced cancers. Nonetheless, in the majority of patients, the successful use of ICIs is limit...
Enregistré dans:
| Publié dans: | Cancers (Basel) |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6770350/ https://ncbi.nlm.nih.gov/pubmed/31443339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11091223 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|